InsidersTradesSigma
健之佳 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Follow the 健之佳 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 健之佳 has recorded 13 reports. Market capitalisation: €3bn. The latest transaction was reported on 25 September 2025 (Purchase). Among the most active insiders: 蓝心悦. Every trade is free.
13
Insider Decl.
0
Thresholds
·
13 ops.
Buy Volume
·
0 ops.
Sell Volume
29Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,078 of 25,956 companies
62.9
score / 100
Value86
Quality40
FCF yld46%
Earn yld6.6%
EV/EBITDA5.7x
ROE5.5%
Gross mgn36%
Net mgn1.7%
Debt/EBITDA3.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 25 September 2025
Declarations13 total
13 of 13 declarations